NCT00641082View on ClinicalTrials.gov

A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

March 31, 2012

Conditions
HBeAg(-) Chronic Hepatitis B With Compensated Liver Function
Interventions
DRUG

Clevudine

30mg for 48 weeks

DRUG

Adefovir dipivoxil

10mg for 48 weeks

Trial Locations (2)

Unknown

Seoul National University Bundang Hospital, Bundang

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT00641082 - A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function | Biotech Hunter | Biotech Hunter